Interleukin-1 Gene Cluster Polymorphism in Chagas Disease in a Colombian Case-Control Study

Human Immunology

Volumn 67, Issue 9, 2006, Pages 741-748

  Flórez, Oscar ^a   Zafra, German ^a   Morillo, Carlos ^b   Martín, Javier ^c   González, Clara Isabel ^a  

^a UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

^b Autonomous Nervous System Unit   (Colombia)

^c INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

Author keywords

Chagas disease; Interleukin 1; Interleukin 1 antagonist; Interleukin 1 receptor; Polymorphism

Indexed keywords

INTERLEUKIN 1;

ADULT; AGED; ALLELE; ARTICLE; CARDIOMYOPATHY; CHAGAS DISEASE; CLINICAL EXAMINATION; COLOMBIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETIC PARAMETERS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROLOGY; STATISTICAL ANALYSIS; TRYPANOSOMA CRUZI;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHAGAS CARDIOMYOPATHY; COLOMBIA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1; MALE; MIDDLE AGED; MULTIGENE FAMILY; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 33748928028     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2006.06.004     Document Type: Article

References (54)

1. WHO Tech Rep Serv 905.i-vi, 1-109, back cover, 2002.
2. Guhl F. Estado actual del control de la enfermedad de Chagas en Colombia. Medicina Buenos Aires 59 Suppl (1999) S103
3. Higuchi M.L., de Brito T., Reis M.M., Aiello V.D., Benvenuti L.A., Gutierrez P.S., Bellotti G., and Pileggi F. Association of an increase in CD8+ T cells with the presence of T. cruziantigens in chronic, human, chagasic myocarditis. Am J Trop Med Hyg 56 (1997) 485
4. Reis M.M., Higuchi M.L., Benvenuti L.A., Aiello V.D., Gutierrez P.S., Bellotti G., and Pileggi F. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol 830 (1997) 165
5. Palomino S.A., Aiello V.D., and Higuchi M.L. Systematic mapping of hearts from chronic chagasic patients: the association between the ocurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann Trop Med Parasitol 94 (2000) 571
6. Higuchi M.L., de Brito T., Reis M.M., Barbosa A., Bellotti G., Pereira-Barreto A.C., and Pileggi F. Correlation between T. cruziparasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc Pathol 2 (1993) 101
7. Tarleton R.L. Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 31 (2001) 550
8. Tarleton R.L. Chagas disease: a role for autoimmunity?. Trends Parasitol 19 (2003) 447
9. Girones N., and Fresno M. Etiology of Chagas disease myocarditis: autoimmunity, parasite persistence, or both?. Trends Parasitol 19 (2003) 19
10. Dos Reis G.A., Freire-de-Lima C.G., Nunes M.P., and Lopes M.F. The importance of aberrant T cell responses in Chagas disease. Trends Parasitol 21 (2005) 237
11. Arend W.P., Malyak M., Guthridge C.J., and Gabay C. Interleukin1 receptor antagonist: a role in biology. Ann Rev Immunol 16 (1998) 27
12. Dinarello C.A. Biological basis for interleukin-1 in disease. Blood 87 (1996) 2095
13. Nicklin M.J., Barton J.L., Nguyen M., FitzGerald M.G., Duff G.W., and Kornman K. A sequenced based map of the nine genes of the human interleukin cluster. Genomics 79 (2002) 718
14. Endres S., Cannon J.G., Ghorbani R., Dempsey R.A., Sisson S.D., Lonnemann G., Van der Meer J.W., Wolf S.M., and Dinarello C.A. In vitro production of IL-1beta, IL-1 alpha, TNF and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 19 (1989) 2327
15. Hall S.K., Perregaux D.G., and Gabel C.A. Correlation of polymorphic variation in the promoter region of the interleukin-1β gene with secretion of interleukin-1β protein. Arthritis Rheum 50 (2004) 1976
16. Hume M., Lahdenpahja N., and Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 30 (1998) 469
17. Layrisse Z., Fernandez M.T., Montagnani S., Matos M., Balbas O., Herrera F., Colorado I.A., Catalioti F., and Acquatella H. HLA-C*03 is a risk factor for cardiomyopathy in Chagas disease. Hum Immunol 61 (2000) 925
18. Colorado I.A., Acquatella H., Catalioti F., Fernandez M.T., and Layrisse Z. HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi infection. Hum Immunol 61 (2000) 320
19. Nieto A., Beraun Y., Collado M.D., Caballero A., Alonso A., Gonzalez A., and Martin J. HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 55 (2000) 195
20. Messias-Reason I.J., Urbanetz L., and Pereira da Cunha C. Complement C3 F and BFS allotypes are risk factors for Chagas disease cardiomyopathy. Tissue Antigens 62 (2003) 308
21. Calzada J.E., Nieto A., Beraun Y., and Martin J. Chemokine receptor CCR5 polymorphisms and Chagas disease cardiomyopathy. Tissue Antigens 58 (2001) 154
22. Beraún Y., Nieto A., Collado M.D., Gonzalez A., and Martin J. Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas disease. Tissue Antigens 52 (1998) 81
23. Ferreira R.C., Ianni B.M., and Abel L.C.J. Increased plasma levels of tumor necrosis factor-α in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 98 (2003) 407
24. Rodríguez J.M., Cruz D., and Hernández G. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett 98 (2005) 97
25. Moreno M., Silva E.L., Ramirez L.E., Palacio L.G., Rivera D., and Arcos-Burgos M. Chagas disease susceptibility/resistance: linkage disequilibrium analysis suggests epistasis between major histocompatibility complex and interleukin-10. Tissue Antigens 64 (2004) 18
26. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 (1988) 1215
27. Calvo J., Martínez N., Etxagibel A., Calleja S., and Saez-Torres C. Allelic frequencies of polymorphic variation of cytokine gene (IL1A, IL1B, IL1RN, IL6, IL10, IL12p40, and INFG) in a Spanish population. Inmunología 21 (2002) 76
28. Sakellari D., Koukoudetsos S., Arsenakis M., and Konstatinidis A. Prevalence of IL1A and IL1B polymorphisms in Greek population. J Clin Periodontol 30 (2003) 35
29. Howell W.M., Turner S.J., Theaker J.M., and Bateman A.C. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenet 30 (2003) 409
30. Cantagrel A., Navaux F., and Loubet-Lescoulie P. Interleukin-1beta, interleukin-1 receptor antagonist, interleukin-4, and interleukin-10 gene polymorphisms: relationship to occurrence and severity of rheumatoid arthritis. Arthritis Rheum 42 (1999) 1093
31. Guasch J.F., Bertina R.M., and Reitsma P.H. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. Cytokine 8 (1996) 598
32. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115
33. Zhao J.H., Curtis D., and Sham P.C. Model-free analysis and permutation tests for allelic associations. Hum Hered 50 (2000) 133
34. Marino A.P.M.P., Silva A.A., Pinho R.T., and Lannes-Viera J. Trypanosoma cruzi infection: a continuous invader-host cell cross talk with participation of extracellular matrix and adhesion and chemoattractant molecules. Braz J Med Biol Res 36 (2003) 1121
35. Chandrasekar B., Melby P.C., Troyer D.A., Colston J.T., and Freeman G.L. Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental chagasic cardiomyopathy. Am J Pathol 152 (1998) 925
36. Petersen C.A., and Burleigh B.A. Role for interleukin-1β in Trypanosoma cruzi induced cardiomyocyte hypertrophy. Infect Immun 71 (2003) 4441
37. Fichera L.E., Albareda M.C., Laucella S.A., and Postan M. Intracellular growth of Trypanosoma cruzi in cardiac myocytes is inhibited by cytokine-induced nitric oxide release. Infect Immun 72 (2004) 359
38. Capon F., Allen M.H., Ameen M., Burden A.D., Tillman D., Barker J.N., and Trembath R.C. A synonymus SNP of corneodesmosin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Hum Mol Genet 13 (2004) 2361
39. Carter M.J., di Giovine F.S., Jones S., Mee J., Camp N.J., Lobo A.J., and Duff G.W. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut 48 (2001) 461
40. Arnalich F., López-Maderuelo D., Codoceo R., López J., Solis-Garrido L.M., Capiscol C., Fernandez-Capitán C., Madero R., and Montiel C. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol 127 (2002) 331
41. Smith A.J.P., Keen L.J., Billinghan M.J., Perry M.J., Elson C.J., Kirwan J.R., Sims J.E., Doherty M., Spector T.D., and Bidwell J.L. Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A, IL1B-IL1RN gene cluster: association with knee osteoarthritis. Genes Immun 5 (2004) 451
42. Hurme M., and Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 28 (1998) 2598
43. Cox A., Camp N.J., Nicklin M.J.H., di Giovine F.S., and Duff G.W. An analysis of linkage desiquilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 62 (1998) 1188
44. Abecasis G.R., Noguchi E., Andrea H., Traherne J.A., Bhattacharyya S., Leaves N.I., Anderson G.G., Zhang Y., Lench N.J., Carey A., Cardon L.R., Moffatt M.F., and Cookson W.O.C. Extent and distribution of linkage disequilibrium in three genomic regions. Am J Hum Genet 68 (2001) 191
45. Nicklin M.J.H., Weith A., and Duff G.W. A physical map of the region encompassing the human interleukin-1α, interleukin-1β, and interleukin-1 receptor antagonist genes. Genomics 19 (1994) 382
46. Clay F.E., Tarlow J.K., Cork M.J., Cox A., Nicklin M.J.H., and Duff G.W. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Human Genet 97 (1996) 723
47. Tseng L.H., Chen P.J., and Lin M.T. Single nucleotide polymorphism in intron 2 of the human interleukin-1 receptor antagonist (IL-1Ra) gene: further definition of the IL-1β and IL-1Ra polymorphisms in North American Caucasians and Taiwanese Chinese. Tissue Antigens 57 (2001) 316
48. Camargo J.F., Correa P.A., Castiblanco J., and Anaya J.M. Interleukin-1β polymorphisms in Colombian patients with autoimmune rheumatic diseases. Genes Immun 5 (2004) 609
49. Timms A.E., Crane A.M., Sims A.M., Cordell H.J., Bradbury L.A., Abbott A., Coyne M.R.E., Beynon O., Herzberg I., Duff G.W., Calin A., Cardon L.R., Wordsworth B.P., and Brown M.A. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 75 (2004) 587
50. Jorde L.B., Watkins W.S., Carlson M., Groden J., Albertsen H., Thliveris A., and Leppert M. Linkage disequilibrium predicts physical distance in the adenomatous polyposis coli region. Am J Hum Genet 54 (1994) 884
51. Vasilescu A., Heath S.C., Ivanova R., Hendel H., Do H., Mazoyer A., Khadivpour E., Goutalier F.X., Khalili K., Rappaport J., Lathrop G.M., Matsuda F., and Zagury J.F. Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes associated with the disease progression. Genes Immun 4 (2003) 441
52. Ardlie K.G., Kruglyak L., and Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet 3 (2002) 299
53. Pritchard J.K., and Przewroski M. Linkage disequilibrium in humans: models and data. Am J Hum Genet 69 (2001) 1
54. Mander A.P. Haplotype analysis in population-based association studies. Stata J 1 1 (2001) 58